Core Points - Northern Lights Resources Corp. announced a non-brokered private placement to raise gross proceeds of up to C$400,000 at a price of $0.05 per Unit [1][2] - Each Unit consists of one common share and one common share purchase warrant, with the warrant exercisable at $0.06 for 36 months [2] - The proceeds will be used for advancing the Horetzky Project and other exploration and working capital needs [2][6] Company Overview - Northern Lights Resources is focused on exploration and development, with key projects including the Horetzky Copper Project in British Columbia and the Secret Pass Gold Project in Arizona [6] - The company also holds a 1% NSR royalty on the Medicine Springs Silver Project in Nevada [6] - Northern Lights trades under the ticker "NLR" on the CSE and "NLRCF" on the OTC [7]

Core Viewpoint - Revive Therapeutics Ltd. is extending its private placement offering to raise up to $650,000, with a first tranche already closed generating $60,900 [1][3]. Group 1: Private Placement Details - The private placement consists of up to 30,952,381 units priced at $0.021 per unit, with gross proceeds expected to be up to $650,000 [1]. - A first tranche of 2,900,000 units was issued at the same price, resulting in total gross proceeds of $60,900 [1]. - The company may close an additional $589,000 worth of units as part of this offering [1]. Group 2: Unit Composition and Terms - Each unit includes one common share and one common share purchase warrant, allowing the holder to acquire one common share at an exercise price of $0.05 for 36 months post-closing [2]. - The issue price per unit is based on the 20-day volume-weighted average price (VWAP) of shares traded on the CSE [2]. Group 3: Use of Proceeds - Gross proceeds from the private placement will be allocated for working capital and payment of certain trade payables [3]. - The private placement may close in multiple tranches, subject to customary closing conditions [3]. Group 4: Company Overview - Revive Therapeutics is focused on developing innovative therapeutics for critical medical needs, leveraging FDA regulatory incentives for rapid advancement [4]. - The company is currently concentrating on Bucillamine for infectious diseases and medical countermeasures, as well as advancing Psilocybin and molecular hydrogen therapeutic programs [4].

Core Points - GAMMA Resources Ltd has successfully closed the first tranche of its private placement, raising gross proceeds of $651,060 [1] - The private placement consists of up to 8,333,334 units priced at $0.12 per unit, aiming for total gross proceeds of up to $1,000,000 [2] - Each unit includes one common share and one warrant, with warrants exercisable at $0.18 for 36 months [2][3] Financial Details - In the first tranche, the company issued 5,425,500 units at $0.12 each, with warrants expiring on September 5, 2028 [3] - Finders' fees amount to $13,650 in cash and 113,750 finders warrants, which have an exercise price of $0.12 for 24 months [3] Related Party Transactions - Directors of the company participated in the first tranche, acquiring a total of 417,000 shares, which is classified as a related party transaction [4] - The offering is exempt from formal valuation and minority shareholder approval requirements as it does not exceed 25% of the company's market capitalization [4] Securities Regulations - All securities from the private placement are subject to a four-month hold period and are not registered under U.S. securities laws [5] - The press release does not constitute an offer to sell or solicit offers to buy securities in the United States [5][9] Company Overview - GAMMA Resources Ltd focuses on uranium exploration and development in the U.S., with key projects in Utah and New Mexico [6] - The company aims to leverage favorable market conditions and policy changes in the U.S. nuclear sector to provide responsibly sourced uranium [6]

Core Points - Pacific Ridge Exploration Ltd. has closed the first tranche of its private placement, raising gross proceeds of C$2,692,920 from the sale of 11,390,000 units at C$0.20 per unit and 1,804,000 flow-through units at C$0.23 per unit [1][9] - The company plans to use the net proceeds for exploration of its Kliyul and RDP copper-gold projects in British Columbia, as well as for general working capital [3] - The offering includes common shares and warrants, with each warrant allowing the purchase of one common share at C$0.28 from November 5, 2025, to September 5, 2028 [2] Financial Details - The total gross proceeds from the sale of flow-through shares will be used for Canadian exploration expenses and flow-through mining expenditures, with an effective date for renouncement not later than December 31, 2025 [4] - Red Cloud Securities Inc. acted as the sole agent and bookrunner for the offering, receiving cash fees of C$132,596.40 and 651,480 non-transferable common share purchase warrants [7] Regulatory Compliance - The units were issued to Canadian purchasers under the listed issuer financing exemption, and the flow-through units were issued under accredited investor and minimum amount investment exemptions [5][6] - The securities issued from the sale of flow-through units and broker warrants are subject to a statutory hold period until January 6, 2026 [8] Insider Participation - Two directors of the company participated in the offering, acquiring a total of 100,000 flow-through units and 100,000 units, which is classified as a related party transaction [10] Company Overview - Pacific Ridge aims to become a leading copper exploration company in British Columbia, with its flagship Kliyul copper-gold project located in a prolific area close to existing infrastructure [13]

Core Points - Sonoro Gold Corp. has increased its non-brokered private placement to 13,350,000 units, raising gross proceeds of CAD $2,002,500 in response to strong investor demand [1][2] - Each unit is priced at CAD $0.15 and includes one common share and one common share purchase warrant, which can be exercised at CAD $0.22 per share for two years [2] - The net proceeds will be allocated to the ongoing development of the Cerro Caliche gold project in Sonora, Mexico, as well as for working capital [4] Company Overview - Sonoro Gold Corp. is a publicly listed exploration and development company focused on the Cerro Caliche project and the San Marcial project in Sonora State, Mexico [5] - The company has a management team with extensive experience in discovering and developing natural resource deposits [5]

Core Viewpoint - Sonoro Gold Corp. has increased its non-brokered private placement to 13,350,000 units, raising gross proceeds of CAD $2,002,500 in response to strong investor demand [1][2]. Group 1: Offering Details - The offering price is set at CAD $0.15 per unit, with each unit consisting of one common share and one common share purchase warrant [2]. - Each warrant allows the holder to purchase an additional common share at an exercise price of CAD $0.22 for a period of two years from the closing of the private placement [2]. - The offering is subject to acceptance by the TSX Venture Exchange and includes a 4-month plus one-day hold period for all securities issued [3]. Group 2: Use of Proceeds - The net proceeds from the offering will be allocated to the ongoing development of the Cerro Caliche gold project in Sonora, Mexico, as well as for working capital [4]. Group 3: Company Overview - Sonoro Gold Corp. is a publicly listed exploration and development company focused on the Cerro Caliche project and the San Marcial project in Sonora State, Mexico [5]. - The company boasts experienced operational and management teams with proven success in discovering and developing natural resource deposits [5].

Core Viewpoint - Purepoint Uranium Group Inc. has successfully closed the final tranche of its private placement, raising a total of $6,000,137.79 to support uranium exploration in the Athabasca Basin, Saskatchewan [1][3]. Financing Details - The final tranche of the private placement included a combination of traditional flow-through units and SK and NT flow-through units, with a total issuance of 772,946 traditional units, 5,768,824 SK units, and 3,041,295 NT units [1][6]. - Each flow-through unit consists of one common share and one common share purchase warrant, with an exercise price of $0.50 per share for a period of 24 months [1]. Use of Proceeds - Proceeds from the private placement will be allocated for the exploration and advancement of the company's projects in the Athabasca Basin [3]. Related Party Transaction - IsoEnergy Ltd. acquired 2,531,646 SK flow-through units, which is classified as a related party transaction as IsoEnergy holds 10.6% of Purepoint's common shares prior to this acquisition [4]. - Following the private placement, IsoEnergy owns approximately 12.57% of Purepoint's issued and outstanding common shares on a non-diluted basis and approximately 18.65% on a partially diluted basis [5]. Finder's Fees - The company paid finders' fees totaling $106,662.14 in cash and issued 264,111 non-transferable compensation warrants to Ventum Financial Corp., Stephen Avenue Securities Inc., and Canaccord Genuity Corp. [2].

Core Viewpoint - WestKam Gold Corp. has received approval from the TSX Venture Exchange to extend the closing date for its non-brokered private placement to September 30, 2025, aiming to raise up to $250,000 through the sale of units priced at $0.07 each [1][2]. Group 1: Private Placement Details - The company is conducting a non-brokered private placement to raise up to $250,000 by selling up to 3,571,428 units, with each unit consisting of one common share and one common share purchase warrant [2]. - Each warrant is exercisable for one common share at a price of $0.10 for a period of two years [2]. - Proceeds from the sale will be used for exploration on the Will Property and for unallocated working capital [3]. Group 2: Regulatory and Compliance Information - The completion of the offering and any finders' fees are subject to necessary regulatory approvals, including those from the TSX Venture Exchange [3]. - All securities issued under the offering will be subject to a hold period of four months and one day from their issuance date [3]. Group 3: Company Overview - WestKam Gold Corp. focuses on acquiring and developing mineral properties in Western Canada, targeting areas with strong potential for significant resources [4].

Core Viewpoint - Nukkleus, Inc. has announced a private placement to raise approximately $10 million to fund strategic acquisitions and business expansion initiatives in the Aerospace and Defense sectors [1][2]. Funding Details - The private placement includes a $9.5 million investment from Esousa Group Holdings, LLC and a $500,000 investment from Sixth Borough Capital Fund, LP [1]. - The company will issue 200 units at a price of $50,000 each, consisting of Series A convertible preferred stock and common warrants [2]. Securities Information - Each Series A convertible preferred stock has a stated value of $50,000 and can be converted into 10,224 unregistered shares of common stock at a conversion price of $4.89 per share [2]. - Common warrants allow the purchase of one share of unregistered common stock at an exercise price of $5.405 per share [3]. Acquisition Plans - The net proceeds will be used for acquiring Tiltan Software Engineering Ltd., a defense market AI software provider, and 51% of Star 26 Capital, which owns RIMON, a supplier for the Iron Dome missile defense system [6]. - The company plans to establish advanced manufacturing zones in the Baltics and Israel through a joint venture with Mandragola Ltd. [6]. - Nukkleus aims to commercialize a drone payload license from Blade Ranger Ltd., marking its entry into commercial aviation services [6]. Closing and Regulatory Information - The closing of the private placement is expected around September 9, 2025, pending customary closing conditions [4]. - The securities are being offered in a private placement exempt from registration requirements under the Securities Act of 1933 [5]. Company Overview - Nukkleus focuses on acquiring and scaling suppliers in the defense, aerospace, and advanced manufacturing sectors, targeting Tier 2 and Tier 3 companies [9]. - The company aims to integrate operational capabilities and financial discipline to modernize and expand strategic suppliers, supporting dual-use innovation and resilient supply chains [10].

Core Viewpoint - ESGold Corp. has announced a brokered private placement offering to raise gross proceeds of up to C$5 million through the sale of units priced at C$0.75 each [1][2]. Group 1: Offering Details - The offering consists of up to 6,666,667 units, each unit comprising one common share and one warrant [1][2]. - Each warrant allows the holder to purchase one common share at a price of C$1.10 within 36 months following the closing date [2]. - The company has granted the agent an option to sell an additional 1,000,000 units for up to C$750,000 in gross proceeds [3]. Group 2: Use of Proceeds - The net proceeds from the offering will be utilized for advancing the Montauban Project in Québec and for general working capital and corporate purposes [4]. Group 3: Regulatory Compliance - The offering will comply with applicable regulatory requirements and will be available to purchasers in specific Canadian provinces, the United States, and offshore jurisdictions [5]. - The securities issued will be freely tradeable in Canada if sold to Canadian residents, without a hold period [5]. Group 4: Closing and Conditions - The offering is scheduled to close on September 18, 2025, subject to necessary regulatory approvals, including that of the Canadian Securities Exchange [7]. Group 5: Company Overview - ESGold Corp. is a pre-production resource company focused on clean mining and exploration, with its flagship Montauban property located 80 kilometers west of Quebec City [10].